Nyquil Cold & Flu Capsules Recalled Due to Rodent Contamination Risk
Gold Star Distribution has recalled Nyquil Cold & Flu 32-count 2-packs distributed nationwide due to insanitary conditions and rodent exposure at their distribution center.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with documented CGMP violations including rodent exposure and insanitary conditions at the distribution facility. Although no illnesses have been reported, this represents a risk-of-harm product where contamination is a genuine concern.
Plain-English summary
Gold Star Distribution Inc. is recalling Nyquil Cold & Flu 32-count 2-packs that were distributed nationwide. The recall affects all lots within their expiration dates that were distributed by the company.
The FDA has classified this as a Class II recall due to Current Good Manufacturing Practice (CGMP) deviations. The company's distribution center was found to have insanitary conditions, including documented rodent exposure and activity.
Consumers who have purchased this product should stop using it and return it to the place of purchase for a refund, or dispose of it safely. Consult a healthcare provider if you have any health concerns related to use of this product.
The recalled product
- Product
- NYQUIL COLD & FLU -32CT/2PK
- Manufacturer
- GOLD STAR DISTRIBUTION INC
- Category
- Drug — OTC Cold & Flu Relief
- Hazard
- contamination
- insanitary-conditions
- rodent-exposure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry distributed by Gold Star Distribution.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27